NCT04626726 2020-11-13Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationHebei Senlang Biotechnology Inc., Ltd.Phase EARLY_PHASE1 Unknown50 enrolled